Canadian Dollar: Oil Gains Offer Constrained Support – HSBC

Featured in:
abcd

HSBC analysts are questioning why the Canadian dollar (CAD) has not strengthened significantly despite higher oil prices, highlighting structural constraints on Canada’s export capacity to the United States. They note that confined LNG and crude oil infrastructure towards Europe and Asia keeps Canadian energy exports largely U.S.-focused and discounted. As a result, HSBC argues that in current conditions, the USD/CAD pair remains more sensitive to broad dollar movements than to oil dynamics.

Oil sensitivity is structurally confined for CAD

“Canada should theoretically benefit from a higher oil price through improved terms of trade and energy revenues. In practice, Canada’s ability to monetize global price spikes is limited by its limited ability to export liquefied natural gas (LNG) and crude oil to Europe and Asia.”

sadasda

“As a result, much of Canada’s energy exports remain U.S.-centric and often trade at a discount, reflecting pipeline bottlenecks and limited exit from the West Coast.”

“Moreover, the biggest spikes in oil prices are often supply shocks that coincide with risk aversion and dollar strength, which could limit CAD growth.”

“In today’s context, even if a prolonged blockage of the Strait of Hormuz causes oil prices to surge, CAD may not gain much.”

(This article was created with the support of an artificial intelligence tool and has been reviewed by an editor.)

abcd
sadasda

Find us on

Latest articles

Related articles

See more articles

Silver Price Forecast: Lower High Structure Holds, Bear Eye...

Silver fell 0.54% during the North American session on Friday, supported by high U.S. Treasury yields and...

Singapore: Resilient GDP and powerful NODX – DBS

DBS economists Radhika Rao and Mo Ji forecast accelerated growth in Singapore's Gross Domestic Product (GDP) in...

British Pound Holds Steady as Trump Tests USD Ceasefire...

The pound sterling (GBP) is holding steady in the North American session on Friday after risk appetite...

Shares: risk and resistance to the AI ​​boom –...

Commerzbank economists Dr. Jörg Krämer and Bernd Weidensteiner argue that the AI-fueled augment in investment in US...

Nurix Therapeutics, Inc. (NRIX) reports a second-quarter loss, delaying...

Nurix Therapeutics, Inc. (NRIX) reported quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of...

The Japanese yen is gaining ground against a weaker...

USD/JPY saw weighty supply during Friday's Asian session and weakened below the 162.00 level as investors remain...